Expert Ratings for Revolution Medicines
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 6 analysts have published their opinion on Revolution Medicines (NASDAQ:RVMD) stock. The majority of these ratings are bullish, with an average 12-month price target of $37.0, which has increased by 7.25% over the past month.
October 12, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts are bullish on Revolution Medicines, with an average 12-month price target of $37.0, indicating potential upside.
The bullish sentiment from analysts, along with the increased price target, suggests that they expect the stock to perform well in the future. This could lead to increased investor interest and a potential rise in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100